In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
Overview Idhifa is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory acute myeloid leukemia (AML) that has tested positive for a mutation in the isocitrate… read more
Join